Collecting blood samples for lab analysis
Official title: Blood Specimen Collection For Laboratory Assay Research
Run by Roman Health Ventures Inc. · NCT06046651 · Data updated 2026-11-12
This study is testing whether blood samples taken from a finger prick can be just as good as traditional blood draws from a vein for helping with medical tests, making it easier and less stressful for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Roman Health Ventures Inc. Industry-sponsored |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | August 16, 2023 |
| Main results expected | July 31, 2033 |
| Study ends | August 15, 2033 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT06046651 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older in good general health who can provide both capillary and venous blood samples.
✕Probably not a fit
Patients unable to provide blood samples due to illness or those with acute or chronic medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect capillary and venous blood specimens to support the development and validation of laboratory procedures. It focuses on the viability of capillary blood samples for diagnostic testing, addressing the challenges of traditional venipuncture methods that can cause patient distress. By comparing the results from capillary samples to the gold standard venous samples, the study seeks to enhance remote health monitoring and improve patient compliance. The research will also explore the stability of these samples under various conditions.
Why it matters
Potential benefit: If successful, this study could improve the accessibility and comfort of blood testing for patients.
How similar studies have gone: While there is limited data on the stability of capillary samples, the approach of using capillary blood for diagnostics is gaining traction and has shown promise in preliminary studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any gender, in good general health * Must be 18 years old or older, inclusive at enrollment * Must be willing to provide capillary blood samples via a fingerstick and venous blood samples, including self-collection and collection by a licensed healthcare professional * Must be able to read, understand, and willingly sign an Informed Consent Form (ICF) and complete a brief health questionnaire * Must be able to read, speak and understand English * Must be available to attend one study visit at Investigator's laboratory or a third-party laboratory designated by the Investigator or collect samples at home, at the discretion of the Investigator. Exclusion Criteria: * Individuals who are unable to provide a blood sample due to any illness * Individuals participating in another research study, that the Investigator feels may compromise study outcomes * Individuals having an acute or chronic disease or medical condition, including pregnancy, which could excessively increase study risk in the opinion of the Investigator or compromise study outcomes * Individuals who are unlikely to be available for the duration of the study
Where it's running
-
Roman Health Ventures Study Site
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Nitin Vaswani, MD — Principal Investigator
- Study coordinator: Nitin Vaswani, MD
- Email: nitin.vaswani@ro.co
- Phone: 7577263449
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PRP injection for female sexual function
This trial tests whether a patient’s own PRP injection into the front vaginal wall can improve sexual function in women with sexual dysfunction.
-
12-Week Solid Beverage Intervention for Suboptimal Health and Metabolic Risk
A 12-week randomized, double-blind study will test a solid beverage containing postbiotics and plant ingredients to see if it improves glucose, lipids, body composition, and metabolic syndrome indicators in overweight or obese adults with mild metabolic abnormalities.
-
Dual treatment with KeraFactor and Revian LED for female pattern hair loss
This study tests whether using a scalp-stimulating serum together with a Revian LED cap helps women with androgenic alopecia grow more hair than each treatment alone or placebo.
-
What predicts religious orientation attitudes in menopausal women
This study tests whether how severe menopausal symptoms and beliefs about sexual myths relate to intrinsic religious orientation in healthy women going through menopause.
-
Sexual function and quality of life in monogamous vs polygamous marriages among Egyptian men
This is a web-based survey to see if marital structure affects erectile function and sexual quality of life in Egyptian men who are married.
-
Scalp hair chemical changes in people with severe obesity and after bariatric surgery
This project will see if chemicals trapped in scalp hair change with body weight and can signal hair thinning or muscle loss in adults having bariatric surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.